Loading…
Company initiates oversubscribed PIPE offering as part of new strategy.
Helius Medical Technologies, a medical technology company, announced yesterday the potential sale of common stock up to $92.8 million. Simultaneously, the company launched a $1.25 billion SOL-backed treasury strategy with an oversubscribed PIPE offering. The common stock sale is proposed at $6.88 per share, while the warrants are priced at $10.13.
The company plans to issue shares of common stock as part of the transaction. The PIPE offering has seen significant interest, leading to its oversubscription. Helius Medical Technologies currently has a free float of 24,506,600 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.